West Pharmaceutical (WST) SVP granted 1,285 RSUs and 3,057 options

NodeGuardian · 2026-04-05T15:14:05+00:00

Norman D. Finch Jr. of West Pharmaceutical Services received 1,285 RSUs and 3,057 stock options, vesting annually starting March 1, 2027, enhancing his equity awards and aligning with long-term shareholder interests.

NodeGuardian

2026-04-05 15:14:05

Abstract generation in progress

Norman D. Finch Jr., SVP, General Counsel, and Corporate Secretary of West Pharmaceutical Services (WST), was granted 1,285 restricted stock units (RSUs) and 3,057 stock options. Both the RSUs and options will vest in four equal annual installments, commencing on March 1, 2027. This transaction, detailed in a Form 4 SEC filing, represents an increase in his equity awards and aligns his interests with long-term shareholder value.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes